Kristie Ann Wagner serves as Executive at Entasis Therapeutics Holdings Inc., where they oversee executive responsibilities. Since joining the company, Kristie Ann Wagner has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 11, 2022 involved selling 80,500 shares valued at $0.
Kristie Ann Wagner currently holds 80,500 shares of Entasis Therapeutics Holdings Inc. (ETTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kristie Ann Wagner has been a net neutral trader of ETTX stock. They have purchased $0 and sold $0 worth of shares.
Kristie Ann Wagner's most recent insider trade was on Jul 11, 2022, when they sold 80,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |